With the development of society and the improvement of people's health awareness, the development trend of the field of biomedicine is also changing. In 2000, the plant capsule was introduced in the United States, leading pharmaceutical and health product companies began to adopt it as an alternative to traditional gelatin capsules due to its all-natural, stable molecular structure and wide adaptability. The US Food and Drug Administration (FDA) has earlier issued guidance that plant-based hollow capsules will make up 80% of the US market within a few years. In the long run, plant capsules instead of animal capsules has become a global development trend.

        Plant capsules have the following advantages:

        First of all, plant capsules do not contain any animal ingredients, avoiding the possible risk of animal disease transmission, in line with modern people's pursuit of food safety and health. In contrast, animal capsules are made using ingredients such as animal collagen, which can come from sources that pose a risk.

        Secondly, the dissolution rate and stability of plant capsules are better, which can well protect the quality and stability of drugs. However, the high water content of gelatin capsules is easy to cross-link with the contents, which may affect the efficacy of drugs. Thirdly, the production process of plant capsules is more environmentally friendly and more in line with the concept of sustainable development. While animal capsules are made using chemicals and preservatives, plant capsules do not require these materials and are more environmentally friendly. Plant capsules replacing gelatin capsules is the development trend of global biomedicine. It has the advantages of better safety, stability and environmental protection. With the continuous development and improvement of plant capsule technology, it is believed that in the future in the field of biological medicine, plant capsules will be more widely used and promoted.

        Tsuen Jikang is a focus on plant hollow capsule, set technology research and development, manufacturing and international marketing as one of the platform company, with independent intellectual property rights, has obtained more than a dozen domestic and international patents. Existing production base in Hebei, annual output of 1.6 billion pilot production base; It plans to distribute six production bases nationwide with an annual output of 100 billion grains. After the project is completed and put into operation, it will accelerate the promotion and application of plant hollow capsule project and promote industrial upgrading.